| 2-15 UPDATE GASTROENTEROLOGY 2-15 UPDATE IN GASTROENTEROLOGY
Annals Int. Med. February 1, 1997; 126: 221-25 reported
from Univ. Of Kansas, Kansas City.
1. A Comparison of Five
Maintenance Therapies for Reflux Esophagitis.
Omeprazole (Prilosec- a proton-pump inhibitor) was more
effective than ranitidine (Zantac-a H2 blocker) alone or
cisapride (Propulsid- a gastrointestinal prokinetic
agent) alone in maintaining remission in patients with
erosive esophagitis. Omeprazole alone was almost as
effective as omeprazole-cisapride combined. NEJM 1995;
333: 1106-10.
2. Accuracy of Invasive
and Noninvasive Tests to Diagnose Helicobacter pylori
Infection.
The C13 urea breath test and measurement of serum IgG H
pylori antibody titers had sensitivity and specificity
similar to invasive tests. Gastroenterology 1995; 109:
136-41
3. Effect of Acid
Suppression of Efficacy of Treatment of Helicobacter
pylori Infection.
Omeprazole, when added to triple antibacterial therapy
(bismuth, metronidazole, and tetracycline), eradicated H
pylori in 98% of patients vs 83% of those receiving
antimicrobial therapy alone. Lancet 1995; 345: 817-20
4. A Comparison of
Symptoms after the Consumption of Milk or
Lactose-hydrolyzed Milk by People with Self-reported
Severe Lactose Intolerance.
When lactose intake was limited to 240 mL of milk per day
gastrointestinal symptoms were likely to be negligible in
patients who had identified themselves as severely
lactose intolerant. NEJM 1995; 333: 1-4
5. Aspirin and the Risk of
Colon Cancer in Women
The relative risk for developing colon cancer decreased
to 0.7 after 10 years of aspirin use and to 0.6 after 20
years. Maximum risk reduction was in those taking 4 to 6
aspirin tablets per week. NEJM 1995; 333: 609-14.
6. An Oral Preparation of
Mesalamine as Long-term Maintenance Therapy for
Ulcerative Colitis.
Mesalamine (Asacol; Pentasa; Rowasa), a 5-amino salicylic
acid analogue, safely and effectively maintained
remission in patients with quiescent ulcerative colitis.
Annals Int. Med. 1996; 124: 204-11
7. Prophylaxis against
Gallstone Formation with Ursodeoxycholic Acid in Patients
Participating in a Very-low-calorie Diet Program.
Gallstones develop in 10% to 25% of patients who rapidly
lose weight through very low calorie diets (eg, 520
Kcal/d). Ursodeoxycholic acid 600 mg/d prevented
gallstone formation. Annals Int. Med. 1995; 122: 899-905
8. Early Antibiotic
Treatment in Acute Necrotizing Pancreatitis.
Infectious complications are a major cause of death in
patients with necrotizing pancreatitis (sepsis caused by
E coli and staph the most common cause).
Treatment with
intravenous cefuroxime (Ceftin) reduced morbidity and
mortality. Lancet 1995; 346: 663-67
[index]
|